Skip to NavigationSkip to content

Pharma R&D hub BioCity appoints new CFO

Published on: 03/11/15

BioCity, the UK bioscience incubator, has appointed Paul Oliver as chief financial officer as it prepares to grow across its four sites in England and Scotland.

Paul Oliver joins BioCity, having previously been chief financial officer of the FTSE 250 pharma company Vectura Group where he helped oversee a major €130m international acquisition and a £52m equity placing on the London Stock Exchange.

On joining BioCity, Oliver says: "I'm excited to be joining such a unique organisation. BioCity is exemplary in the way it supports, nurtures and invests in early stage biotech companies and I look forward to helping BioCity continue the excellent progress it has made to date."

Speaking about Paul Oliver's appointment, BioCity CEO Glenn Crocker says: "We are delighted to welcome Paul to BioCity at this exciting period in the Company's growth. Paul is an established and well-regarded CFO, who has gained considerable relevant experience within the UK pharmaceutical industry. His strong financial control, market knowledge and transaction experience will be a considerable asset for BioCity.” 

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches